• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CORT

CORT

Corcept Therapeutics Incorporated

NASDAQHealthcareBiotechnologyUS

USD72.65

+1.45 (+2.04%)

Rating:B+

Company Profile

CEO

Joseph K. Belanoff

IPO Date

2004-04-14

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$70.93

Prev. Close

$71.20

Day Low

$70.31

Day High

$72.94

52W Low

$28.66

52W High

$91.00

Market Cap

$7.80B

Volume

0.78M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

19.5%

Avg Negative

3.5%

Avg Neutral

76.9%

News Feed

William Guyer to join Corcept as Chief Development Officer

GlobeNewsWire·8/12/2021·↓ negative

Corcept's (CORT) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Zacks Investment Research·7/30/2021·↑ positive

Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/29/2021·↓ negative

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

GlobeNewsWire·7/29/2021·↑ positive

Corcept Therapeutics To Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

GlobeNewsWire·7/22/2021·↓ negative

Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer

GlobeNewsWire·7/12/2021·↑ positive

Corcept Therapeutics Stock Drops After Disappointing Interim Data From Relacorilant Plus Nab-Paclitaxel Trial In Pancreatic Cancer

Benzinga·6/22/2021·↑ positive

Preliminary Results From RELIANT Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer

GlobeNewsWire·6/22/2021·↑ positive

Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical

GlobeNewsWire·6/15/2021·↑ positive

Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors

GlobeNewsWire·6/10/2021·↑ positive